Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1 / 5 Announcement Summary Entity name CAMBIUM BIO LIMITED Date of this announcement Wednesday September 02,...
Notification regarding unquoted securities - CMB
Filed with ASX · · 5 pages · English
Release
Earlier from Cambium Bio
- Proposed issue of securities - CMB
- FY26 Appendix 4E and Annual Report
- FY26 Appendix 4G and Corporate Governance Statement
- Change in Company Secretary and Communication Person
- Updated Securities Trading Policy
Later from Cambium Bio
- Update - Proposed issue of securities - CMB
- Change in Substantial Holding
- Notice of ceasing to be a substantial holder
- Cambium Bio Secures A$10.85 Million Funding Package
- Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye Disease
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio